Robert Goldberg

CMPI Founders

Robert Goldberg, PhD

Robert Goldberg is co-founder and vice president of the Center for Medicine in the Public Interest. (CMPI) Along with Peter Pitts, Dr. Goldberg hosts the popular and controversial blog on the pharmaceutical industry and healthcare, www.drugwonks.com.

Prior to founding CMPI, Goldberg was Director of the Manhattan Institute’s Center for Medical Progress and Chairman of its 21st Century FDA Task Force which examined the impact of the FDA’s Critical Path Initiative on drug development and personalized medicine.

He has written for The Wall Street Journal, The Washington Post, the Los Angeles Times, National Review Online, The Chicago Tribune, The Philadelphia Inquirer, The New York Sun and writes regularly for The Washington Times, the New York Post and The Weekly Standard.

He is an expert on Medicare reform, comparative effectiveness and FDA’s Critical Path Initiative. He is author, with Peter Pitts of “Keeping Medicine Personal: A Critical Path for Comparative Effectiveness,” a recent CMPI white paper, The Impact of Medicare’s Anemia Drug Coverage Decision On Cancer Patients: Comparative Effectiveness vs. Patient Centered-Care, Insta-Americans: The Empowered (and Imperiled) Health Care Consumer in the Age of Internet Medicine, and with John Vernon, "Alzheimer's Disease and Cost-effectiveness Analyses: Ensuring Good Value for Money?"

Dr. Goldberg lives in Springfield NJ. He has a daughter Sara, age 24 and a son Zach, age 21.  He received his PhD from Brandeis University in 1984 and is a Yankees fan. 

Featured

Healthcare summit as interesting as Olympic curling
February 25, 2010  
Maine’s drug-disposal bill should be thrown out
February 19, 2010  
Ambiguity is Power
February 17, 2010  

Stay Informed

Receive latest news & event updates
Provide email below:


Bookmark and Share